Better Medicine
Better Medicine builds CE-certified AI software that detects, classifies, and measures cancer lesions on CT scans, selling to hospitals, radiology departments, AI platforms, and — via Image Analysis Group — oncology clinical trial sponsors, primarily in Europe.
- Company typePrivate
- Founded2020
- HeadquartersTartu, Estonia
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Better Medicine does
Better Medicine OÜ is an Estonian medical technology company founded in 2020 in Tartu that develops AI-powered radiology diagnostics software for cancer detection on CT scans. The platform, branded BMVision, applies a multi-organ approach — covering kidney, lung, and an announced roadmap of liver, pancreas, lymph nodes, and bones — to automated lesion detection, classification, segmentation, and quantification, with BMVision Kidney holding CE Class IIa certification under EU MDR (described as the world's first MDR-certified kidney cancer AI) and BMVision Lung trained on 1,200+ patient datasets. Supporting products include BMViewer, a custom radiology viewer with integrated AI findings; BMGateway, which handles DICOM/PACS integration and de-identification with AWS, Google Cloud, Azure, and SFTP compatibility; and iMeasure, a semi-automated lesion measurement tool for reducing inter-observer variability.
Better Medicine firmographics
Firmographics- Name
- Better Medicine
- Legal name
- Better Medicine OÜ
- Website
- https://bettermedicine.ai
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Better Medicine builds CE-certified AI software that detects, classifies, and measures cancer lesions on CT scans, selling to hospitals, radiology departments, AI platforms, and — via Image Analysis Group — oncology clinical trial sponsors, primarily in Europe.
- Ownership category
- akta.pro rank
Better Medicine industry classification
Industry- Product category
- Medical Imaging AI / Radiology Diagnostics Software
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ)
- akta.pro secondary industries
- Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic) (HLACALAD), Imaging Interoperability & Standards Enablement (DICOM/HL7/FHIR/IHE) (HLACALAJ), AI Orchestration & Imaging Analytics Platforms (Model Management/Triage) (HLACALAG), Radiology Reporting, Dictation & Structured Reporting (HLACALAF)
Keywords
Where Better Medicine is headquartered
LocationHeadquarters
- HQ city
- Tartu
- HQ country
- Estonia
- HQ region
- Europe
Offices3 records
Markets served
Better Medicine business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Revenue model
- AI Diagnostics Software Licensing: Better Medicine licenses its AI-powered radiology diagnostics software (BMVision, BMViewer, BMGateway) to healthcare providers, hospitals, radiology departments, and clinical research organizations. Revenue is generated through software licensing agreements, likely with subscription or per-use pricing models for medical device software.
- Clinical Trial Imaging Services: Through partnership with Image Analysis Group, Better Medicine provides AI-powered tumor assessment technology integrated into clinical trial workflows for biotech and pharma sponsors, enabling accelerated oncology drug development.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Better Medicine product offering
Product offeringCore offering
Better Medicine develops and licenses AI-powered radiology diagnostic software that performs automated detection, classification, and quantification of cancer lesions on CT scans across multiple organs including kidney and lung. Its flagship BMVision platform integrates with PACS systems and DICOM viewers to assist radiologists with cancer screening, lesion measurement, and automated reporting. The suite includes BMVision Kidney (CE-certified as a Class IIa medical device), BMVision Lung, BMViewer (custom radiology viewer), BMGateway (data management), and iMeasure (semi-automated lesion measurement).
Product overview
Better Medicine offers a modular AI-powered radiology diagnostics platform centered on BMVision, the world's first clinically validated multi-organ cancer detection solution. The platform follows a platform-plus-modules architecture: BMVision serves as the core AI engine with certified organ-specific modules for kidney (BMVision Kidney) and lung (BMVision Lung), plus upcoming models for liver, pancreas, lymph nodes, and bones. Supporting the AI models are three complementary products: BMViewer provides a custom-built radiology viewer with integrated AI tooling, BMGateway handles automated medical data management and PACS integration with de-identification workflows, and iMeasure delivers semi-automated lesion measurement across all organs. The integrated suite enables radiologists to detect, classify, quantify, and track lesions from a single scan while automating reporting workflows.
Differentiator
Problem solved
Functional benefit
Brands
- BMVision: Multi-organ radiology AI software for full-body cancer detection, including kidney, lung, and upcoming organs (liver, pancreas, lymph nodes, bones).
- BMViewer
- BMGateway
Products and services
- BMVision Full-body AI platform providing multi-organ cancer detection across kidney, lung, and upcoming organs (liver, pancreas, lymph nodes, bones). Detects, classifies, and measures lesions on CT scans with automated 3D segmentation and classification into benign or malignant categories. Designed for radiologists in clinical diagnostic workflows.
- BMVision Kidney World's first and only clinically validated and MDR-certified kidney cancer AI solution for automated detection, classification, and quantification of renal lesions on CT scans. Achieves 99.2% sensitivity in detecting patients with kidney cancer and reduces lesion detection disagreement among radiologists by 34.3%.
- BMVision Lung AI lung cancer detection solution enhancing radiologists' performance with 91.6% sensitivity in lung nodule detection, automated nodule classification, quantification, and monitoring. Supports LUNG-RADS 2022 criteria for standardized assessment and management categorization with Volume Doubling Time estimation.
- BMViewer Custom-built medical imaging viewer designed by radiologists for clinical research. Integrates AI findings, high-quality DICOM image rendering, automated reporting, advanced annotation tools, and lesion measurement capabilities for radiology departments and clinical research workflows.
- BMGateway AI-driven medical data management software for clinical workflow integration. Enables automated patient scan selection, de-identification and pseudonymisation of patient data with envelope encryption, and customisable data export to DICOM nodes and cloud providers including AWS, Google Cloud, and Microsoft Azure.
Quantifiable outcome
- 99.2% sensitivity in detecting patients with kidney cancer when radiologists use BMVision
- +5 more outcomes
Companies that use Better Medicine
Customer profileNamed customers8 records
Segments3 records
Ideal customer profiles3 records
Better Medicine technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability6 records
Feature5 records
Better Medicine partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- Image Analysis Group (IAG)coreStrategic partnership to integrate Better Medicine's AI-powered tumor assessment technology into IAG's proprietary DYNAMIKA platform for oncology clinical trials. The integration enables automated tumor identification, measurement, and tracking across CT scans, reducing central read turnaround times and imaging costs while maintaining regulatory-grade quality for biotech and pharma sponsors.
- Latitude59minorBetter Medicine presented at Estonia's prominent startup and technology conference Latitude59 (May 20-22), expressing interest in partnering with India and accessing its market. The conference facilitates networking between Estonian startups and international investors and partners.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Better Medicine competitors and assessment
Company assessmentDirect peers
- Aidoc: Aidoc is a leading AI radiology platform offering a suite of FDA-cleared algorithms across multiple body regions and use cases (CT triage, stroke, PE, etc.), directly competing with Better Medicine's multi-organ CT cancer detection strategy and AI-platform marketplace model.
- Annalise.ai: Annalise.ai provides comprehensive multi-finding AI for chest and other CT/X-ray studies with broad abnormality detection, directly overlapping with BMVision's full-body, multi-organ approach and competing for the same hospital AI buyer.
- Qure.ai: Qure.ai builds AI for medical imaging across CT, MRI, and X-ray for head, chest, and musculoskeletal use cases, overlapping with Better Medicine's CT-based lesion detection, classification, and quantification capabilities on a global commercial scale.
- Lunit: Lunit develops radiology AI (notably Lunit INSIGHT for chest and mammography) with FDA-cleared and CE-marked products, competing head-to-head with BMVision Lung in lung nodule detection and with broader cancer-detection portfolios.
- Aidence (DeepHealth): Aidence, now part of DeepHealth (a RadNet subsidiary), focuses on AI for lung nodule detection and management on CT, directly competing with BMVision Lung and sharing a similar European origin and clinical workflow positioning.
- Viz.ai: Viz.ai offers a portfolio of FDA-cleared radiology AI workflows (notably stroke and cardiac) integrated into a platform with care coordination features, paralleling Better Medicine's platform approach of AI modules + viewer + workflow integration.
- Riverain Technologies: Riverain Technologies builds AI for chest CT and X-ray focused on lung nodule and oncology detection, overlapping directly with BMVision Lung's indication and CE/FDA regulatory positioning.
Emerging players
- Arterys: Arterys provides cloud-native medical imaging AI platform with multi-organ clinical apps and developer tools, comparable to Better Medicine's BMGateway/BMViewer integration plus AI-model approach in the oncology imaging space.
Others
- Deepc: Deepc is an AI radiology platform and marketplace partner that lists certified third-party AI algorithms (including Better Medicine's kidney cancer AI) on its platform; it is a channel partner rather than a direct product competitor.
- CARPL: CARPL is a radiology AI marketplace and integration platform that hosts certified third-party AI vendors including Better Medicine's modules, functioning as a distribution and validation partner rather than a head-to-head product competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Better Medicine social profiles
Digital presenceBetter Medicine compliance and trust
Trust signalCompliance3 records
Better Medicine financial estimates
Financial estimateRevenue estimate
Valuation estimate
Better Medicine leadership team
Management profileNumber of profiles
Profiles6 records
Better Medicine funding detail
Funding detailFunding overview
Funding rounds2 records
Investors4 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Better Medicine M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Better Medicine
What does Better Medicine do?
Better Medicine develops and licenses AI-powered radiology diagnostic software that performs automated detection, classification, and quantification of cancer lesions on CT scans across multiple organs including kidney and lung. Its flagship BMVision platform integrates with PACS systems and DICOM viewers to assist radiologists with cancer screening, lesion measurement, and automated reporting. The suite includes BMVision Kidney (CE-certified as a Class IIa medical device), BMVision Lung, BMViewer (custom radiology viewer), BMGateway (data management), and iMeasure (semi-automated lesion measurement).
Is Better Medicine a public or private company?
Better Medicine is a private company. It is classified as venture growth investor backed and is currently operating.
When was Better Medicine founded?
Better Medicine was founded in 2020. It employs 11 to 50 people.
Where is Better Medicine based?
Better Medicine is headquartered in Tartu, Estonia, in the Europe region.
How does Better Medicine make money?
Two revenue lines are on record. AI Diagnostics Software Licensing is the primary driver. The others are clinical Trial Imaging Services.
Who are Better Medicine's main competitors?
Direct peers on record are Aidoc, Annalise.ai, Qure.ai, Lunit, Aidence (DeepHealth), Viz.ai and Riverain Technologies. Arterys is listed as an emerging player. Others are Deepc and CARPL.
Does Better Medicine have an API?
No public API is recorded for Better Medicine.
What industry is Better Medicine in?
Better Medicine's product category is Medical Imaging AI / Radiology Diagnostics Software. Its primary akta.pro industry code is HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software, with a secondary code of HLACALAD, Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic). Its NAICS code is 54171 and its SIC code is 3841.